DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Ruboxistaurin is an investigational drug.
There have been 13 clinical trials for Ruboxistaurin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2002.
The most common disease conditions in clinical trials are Diabetes Mellitus, Diabetes Mellitus, Type 1, and Diabetic Neuropathies. The leading clinical trial sponsors are Chromaderm, Inc., Eli Lilly and Company, and Children's Hospital Medical Center, Cincinnati.
Recent Clinical Trials for Ruboxistaurin
|Ruboxistaurin in New York Heart Failure Classification III-IV Patients||The Christ Hospital||Phase 1/Phase 2|
|Ruboxistaurin in New York Heart Failure Classification III-IV Patients||Children's Hospital Medical Center, Cincinnati||Phase 1/Phase 2|
|Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus||Heart and Stroke Foundation of Canada||Phase 3|